e-learning
resources
Barcelona 2013
Saturday, 07.09.2013
PG6 Epigenetics of asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The environment, epigenetics and lung disease
H. M. Boezen (Groningen, The Netherlands)
Source:
Annual Congress 2013 –PG6 Epigenetics of asthma and COPD
Session:
PG6 Epigenetics of asthma and COPD
Session type:
Postgraduate Course
Number:
17
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. M. Boezen (Groningen, The Netherlands). The environment, epigenetics and lung disease. Annual Congress 2013 –PG6 Epigenetics of asthma and COPD
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Impact of genetic factors on lung development in health and disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=93
Year: 2006
Host–microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease
Source: Eur Respir J, 56 (2) 1902320; 10.1183/13993003.02320-2019
Year: 2020
An introduction to mitochondria in lung biology and disease
Source: International Congress 2018 – Mitochondrial dysfunction as a driver of lung disease
Year: 2018
The biology of lung cancer
Source: Eur Respir Mon; 2009: 44: 88–105
Year: 2009
The genetics of interstitial lung diseases
Source: Eur Respir Rev, 28 (153) 190053; 10.1183/16000617.0053-2019
Year: 2019
Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology
Source: Eur Respir J 2010; 35: 496-504
Year: 2010
Smoking-induced lung disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=134
Year: 2007
Siphonage lung disease
Source: Virtual Congress 2020 – Respiratory critical care
Year: 2020
The lung microbiome in obstructive airways disease: potential pathogenetic roles
Source: Eur Respir Monogr 2019; 83: 140-157
Year: 2019
The consequences of microbiome and pathogen dynamics for chronic lung diseases
Source: Annual Congress 2012 - The bacterial microbiota: implications for health and disease - joint session with the World Allergy Organisation
Year: 2012
Stratified medicine: drugs meet genetics
Source: Eur Respir Rev 2013; 22: 53-57
Year: 2013
The potential of epigenetic editing in chronic lung disease
Source: International Congress 2018 – Organoids and pluripotent stem cells
Year: 2018
Novel insights into the genetics of smoking behaviour, lung function and chronic obstructive pulmonary disease in UK Biobank
Source: International Congress 2015 – Asthma: emerging risk factors and current management of the patient
Year: 2015
Local genetic and environmental factors in asthma disease pathogenesis: chronicity and persistence mechanisms
Source: Eur Respir J 2007; 29: 793-803
Year: 2007
Interstitial lung disease induced by exogenous agents: factors governing susceptibility
Source: Eur Respir J 2001; 18: 30S-42S
Year: 2001
Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease?
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept